Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma

Cancer Research

Volumn 63, Issue 18, 2003, Pages 6069-6075

  Twine, Natalie C ^a   Stover, Jennifer A ^a   Marshall, Bonnie ^a   Dukart, Gary ^a   Hidalgo, Manuel ^b   Stadler, Walter ^c   Logan, Theodore ^d   Dutcher, Janice ^e   Hudes, Gary ^f   Dorner, Andrew J ^a   Slonim, Donna K ^a   Trepicchio, William L ^a,g   Burczynski, Michael E ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d INDIANA UNIVERSITY   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; OLIGONUCLEOTIDE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; KIDNEY CARCINOMA; MALE; MOLECULAR PROBE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0141842620     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
2. Moch, H., Gasser, T., Amin, M. B., Torhorst, J., Sauter, G., and Mihatsch, M. J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer (Phila.), 89: 604-614, 2000.
3. Minasian, L. M., Motzer, R. J., Gluck, L., Mazumdar, M., Vlamis, V., and Krown, S. E. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. J. Clin. Oncol., 11: 1368-1375, 1993.
4. Slonim, D. K. Transcriptional profiling in cancer: the path to clinical pharmacogenomics. Pharmacogenomics. 2: 123-136, 2001.
5. Young, A. N., Amin, M. B., Moreno, C. S., Lim, S. D., Cohen, C., Petros, J. A., Marshjall, F. F., and Neish, A. S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol., 158: 1639-1651, 2001.
6. Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E. L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol., 14: 1675-1680, 1996.
7. Hill, A. A., Brown E. L., Whitley, M. Z., Tucker-Kellogg, G., Hunter, C. P. and Slonim, D. K. Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls. Genome Biol., 2: research 0055.1-0055.13, 2001.
8. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
9. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
10. Slonim, D. K., Tamayo, P., Mesirov, J. P., Golub, T. R., and Lander, E. S. Class prediction and discovery using gene expression data. Proc. Fourth Annual Conference on Computational Molecular Biology, 263-272, 2000.
11. Whitney, A. R., Diehn, M., Popper, S. J., Alizadeh, A. A., Boldrick, J. C., Relman, D. A., and Brown, P. O. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. USA, 100: 1896-1901, 2003.
12. Martin, K. J., Graner, E., Li, Y., Price, L. M., Kritzman, B. M., Fournier, M. V., Rhei, E., and Pardee, A. B. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc. Natl. Acad. Sci. USA. 98: 2646-2651, 2001.
13. Taback, B., Chan, A. D., Kuo, C. T., Bostick, P. J., Wang, H. J., Giuliano, A. E., and Hoon, D. S. Detection of occult metastatic breast cancer cells in blood by a multi-molecular marker assay: correlation with clinical stage of disease. Cancer Res., 61: 8845-8850, 2001.
14. Melief, C. J., and Kast, W. M. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. Semin. Cancer Biol., 2: 347-354, 1991.
15. Zelle-Rieser, C., Barsoum, A. L., Sallusto, F., Ramoner, R., Rohrer, J. W., Holtl, L., Bartsch, G., Coggin, J. H., Jr., and Thurnher M. Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma. J. Urol., 165: 1705-1709, 2001.
16. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C. H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., Poggio, T., Gerald, W., Loda, M., Lander, E. S., and Golub, T. R. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci., USA, 98: 15149-15154, 2001.
17. Petricoin, E. F., III, Hackett, J. L., Lesko, L. J., Puri, R. K., Gutman, S. I., Chumakov, K., Woodcock. J., Feigal, D. W., Jr., Zoon, K. C., and Sistare, F. D. Medical applications of microarray technologies: a regulatory science perspective. Nat. Genet., 32: 474-479, 2002.
18. Swanson B. N. Delivery of high quality biomarker assays. Dis. Markers, 18: 47-56, 2002.